Interest of selective progesterone receptor modulators in endometriosis

被引:5
|
作者
Merviel, P. [1 ]
Lourdel, E. [1 ]
Sanguin, S. [1 ]
Gagneur, O. [1 ]
Cabry, R. [1 ]
Nasreddine, A. [1 ]
机构
[1] CHU Amiens, Ctr AMP, Ctr Gynecol Obstet, F-80054 Amiens 1, France
来源
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2013年 / 41卷 / 09期
关键词
Endometriosis; SPRM; Ulipristal acetate; Pelvic pain; Endometrium; ULIPRISTAL ACETATE; CYCLOOXYGENASE-2; MIFEPRISTONE; ANTAGONISTS; EXPRESSION;
D O I
10.1016/j.gyobfe.2013.07.016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The SPRM (selective progesterone receptor modulators) are agonists and/or antagonists of progesterone receptor. They are responsible for anovulation, amenorrhea and a lower prostaglandin levels, which leads to an improvement in pain and regression of lesions in endometriosis. On the endometrium, a particular aspect, the progesterone receptor modulator-associated endometrial changes (PAEC), raises additional studies to verify its harmlessness. However, due to the lack of hypoestrogenism and metabolic effects with these drugs, it is very likely that the SPRM will in the near future an important place in the treatment of endometriosis. (C) 2013 Published by Elsevier Masson SAS.
引用
收藏
页码:524 / 528
页数:5
相关论文
共 50 条
  • [31] Analysis of the growing public interest in selective androgen receptor modulators
    Efimenko, Iakov, V
    Chertman, Willy
    Masterson, Thomas A.
    Dubin, Justin M.
    Ramasamy, Ranjith
    ANDROLOGIA, 2021, 53 (11)
  • [32] Selective progesterone receptor modulators: Mechanisms of action and possible clinical applications
    Selgrad C.
    Ortmann O.
    Gynäkologische Endokrinologie, 2016, 14 (1) : 44 - 48
  • [33] Selective progesterone receptor modulators 3: use in oncology, endocrinology and psychiatry
    Benagiano, Giuseppe
    Bastianelli, Carlo
    Farris, Manuela
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (14) : 2487 - 2496
  • [34] Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators
    Pintiaux, Axelle
    Chabbert-Buffet, Nathalie
    Foidart, Jean-Michel
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (02) : 67 - 73
  • [35] Preclinical experience with two selective progesterone receptor modulators on breast and endometrium
    Kloosterboer, HJ
    Deckers, GH
    Schoonen, WGEJ
    Hanssen, RGJM
    Rose, UM
    Verbost, PM
    Hsiu, JG
    Williams, RF
    Hodgen, GD
    STEROIDS, 2000, 65 (10-11) : 733 - 740
  • [36] Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis
    Chwalisz, K
    Perez, MC
    DeManno, D
    Winkel, C
    Schubert, G
    Elger, W
    ENDOCRINE REVIEWS, 2005, 26 (03) : 423 - 438
  • [37] ORGN 661-Selective progesterone receptor antagonists for the treatment of endometriosis
    Dack, Kevin N.
    Johnson, Patrick S.
    Bradley, Paul A.
    Skerratt, Sarah
    Marsh, Ian R.
    Underwood, Toby
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [38] Progesterone antagonists and progesterone receptor modulators: an overview
    Spitz, IM
    STEROIDS, 2003, 68 (10-13) : 981 - 993
  • [39] Progesterone receptor modulators Reply
    Critchley, Hilary
    Wilkens, Julia
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2010, 36 (03): : 179 - 179
  • [40] Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies
    Wagenfeld, Andrea
    Saunders, Philippa T. K.
    Whitaker, Lucy
    Critchley, Hilary O. D.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (09) : 1045 - 1054